TIRELLI, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 771
EU - Europa 202
AS - Asia 168
OC - Oceania 1
Totale 1.142
Nazione #
US - Stati Uniti d'America 765
CN - Cina 112
UA - Ucraina 81
DE - Germania 46
FI - Finlandia 34
HK - Hong Kong 22
IE - Irlanda 14
SG - Singapore 14
IN - India 13
GB - Regno Unito 9
FR - Francia 7
IT - Italia 6
CA - Canada 5
IR - Iran 4
SE - Svezia 2
AU - Australia 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
JP - Giappone 1
LU - Lussemburgo 1
MS - Montserrat 1
TR - Turchia 1
Totale 1.142
Città #
Woodbridge 125
Fairfield 91
Houston 69
Jacksonville 65
Ashburn 63
Ann Arbor 52
Chandler 49
Seattle 46
Cambridge 42
Wilmington 39
Nanjing 33
Princeton 27
Beijing 22
Hong Kong 22
Helsinki 21
Dublin 14
New York 12
Nanchang 10
San Diego 9
Singapore 8
Shanghai 7
Tianjin 7
Des Moines 6
Shenyang 6
Jinan 5
Toronto 5
Ardabil 4
Kunming 4
Changsha 3
Hebei 3
Lancaster 3
Milan 3
Guangzhou 2
Jiaxing 2
Los Angeles 2
Norwalk 2
Phoenix 2
Brescia 1
Brno 1
Changchun 1
Dhaka 1
Haikou 1
Hangzhou 1
Lanzhou 1
Leawood 1
Luxembourg 1
Melbourne 1
Monza 1
Ningbo 1
Pune 1
San Francisco 1
Taizhou 1
Verona 1
Zhengzhou 1
Totale 902
Nome #
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 118
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 108
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 102
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 101
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 98
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 98
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 96
Observational Study on HIV-Infected Subjects Failing HAART Receiving Tenofovir Plus Didanosine as NRTI Backbone. 90
Potential role of SEN virus on liver enzyme abnormalities in patients positive for hepatitis C virus with or without HIV infection. 86
Lopinavir plasma levels in salvage regimens by a population of highly active antiretroviral therapy-treated HIV-1-positive patients. 61
Current concerns in HIV antiretroviral therapy 51
Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case 51
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 49
Infezione da HIV. Terapia 38
Totale 1.147
Categoria #
all - tutte 4.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 50 10 9 46 18 32 30 32 27 40 9 17
2020/2021170 3 16 4 23 5 29 5 21 27 13 17 7
2021/202299 7 9 0 4 0 9 4 4 6 15 9 32
2022/2023125 15 4 0 4 12 43 0 11 21 0 5 10
2023/202497 6 1 7 20 1 17 1 4 22 2 2 14
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.147